S&P 500   4,387.45 (-0.51%)
DOW   34,427.60 (+0.18%)
QQQ   350.67 (-0.74%)
AAPL   162.57 (+0.59%)
MSFT   294.71 (-0.56%)
FB   305.90 (-0.91%)
GOOGL   2,581.62 (-1.32%)
AMZN   2,837.40 (-1.85%)
TSLA   950.10 (+2.16%)
NVDA   228.75 (-2.13%)
BABA   120.68 (+0.26%)
NIO   24.43 (-1.77%)
AMD   114.06 (-2.12%)
CGC   7.50 (+1.35%)
MU   82.30 (-0.78%)
GE   92.16 (-4.90%)
T   26.55 (+0.80%)
F   20.27 (-0.59%)
DIS   137.61 (+0.11%)
AMC   16.33 (-1.86%)
PFE   52.75 (+2.35%)
ACB   4.29 (-0.69%)
BA   205.31 (+0.54%)
S&P 500   4,387.45 (-0.51%)
DOW   34,427.60 (+0.18%)
QQQ   350.67 (-0.74%)
AAPL   162.57 (+0.59%)
MSFT   294.71 (-0.56%)
FB   305.90 (-0.91%)
GOOGL   2,581.62 (-1.32%)
AMZN   2,837.40 (-1.85%)
TSLA   950.10 (+2.16%)
NVDA   228.75 (-2.13%)
BABA   120.68 (+0.26%)
NIO   24.43 (-1.77%)
AMD   114.06 (-2.12%)
CGC   7.50 (+1.35%)
MU   82.30 (-0.78%)
GE   92.16 (-4.90%)
T   26.55 (+0.80%)
F   20.27 (-0.59%)
DIS   137.61 (+0.11%)
AMC   16.33 (-1.86%)
PFE   52.75 (+2.35%)
ACB   4.29 (-0.69%)
BA   205.31 (+0.54%)
S&P 500   4,387.45 (-0.51%)
DOW   34,427.60 (+0.18%)
QQQ   350.67 (-0.74%)
AAPL   162.57 (+0.59%)
MSFT   294.71 (-0.56%)
FB   305.90 (-0.91%)
GOOGL   2,581.62 (-1.32%)
AMZN   2,837.40 (-1.85%)
TSLA   950.10 (+2.16%)
NVDA   228.75 (-2.13%)
BABA   120.68 (+0.26%)
NIO   24.43 (-1.77%)
AMD   114.06 (-2.12%)
CGC   7.50 (+1.35%)
MU   82.30 (-0.78%)
GE   92.16 (-4.90%)
T   26.55 (+0.80%)
F   20.27 (-0.59%)
DIS   137.61 (+0.11%)
AMC   16.33 (-1.86%)
PFE   52.75 (+2.35%)
ACB   4.29 (-0.69%)
BA   205.31 (+0.54%)
S&P 500   4,387.45 (-0.51%)
DOW   34,427.60 (+0.18%)
QQQ   350.67 (-0.74%)
AAPL   162.57 (+0.59%)
MSFT   294.71 (-0.56%)
FB   305.90 (-0.91%)
GOOGL   2,581.62 (-1.32%)
AMZN   2,837.40 (-1.85%)
TSLA   950.10 (+2.16%)
NVDA   228.75 (-2.13%)
BABA   120.68 (+0.26%)
NIO   24.43 (-1.77%)
AMD   114.06 (-2.12%)
CGC   7.50 (+1.35%)
MU   82.30 (-0.78%)
GE   92.16 (-4.90%)
T   26.55 (+0.80%)
F   20.27 (-0.59%)
DIS   137.61 (+0.11%)
AMC   16.33 (-1.86%)
PFE   52.75 (+2.35%)
ACB   4.29 (-0.69%)
BA   205.31 (+0.54%)
NASDAQ:SRRK

Scholar Rock News Headlines

$18.68
+0.14 (+0.76%)
(As of 01/25/2022 03:02 PM ET)
Add
Compare
Today's Range
$17.61
$18.80
50-Day Range
$17.76
$34.93
52-Week Range
$16.85
$70.00
Volume
3,935 shs
Average Volume
184,573 shs
Market Capitalization
$655.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.1
Get Scholar Rock News Delivered to You Automatically

Sign up to receive the latest news and ratings for SRRK and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Scholar Rock Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SRRK
News Sentiment

-0.21

0.35

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SRRK Articles
This Week

5

1

SRRK Articles
Average Week



Scholar Rock (NASDAQ:SRRK) News Headlines Today

SourceHeadline
finance.yahoo.com logoScholar Rock to Present Biomarker Strategy for SRK-181 at the TGFβ for Immuno-Oncology Drug Development Summit
finance.yahoo.com - January 25 at 10:58 AM
MarketBeat logoScholar Rock (NASDAQ:SRRK) Sets New 1-Year Low at $16.85
americanbankingnews.com - January 25 at 4:04 AM
MarketBeat logo-$1.04 Earnings Per Share Expected for Scholar Rock Holding Co. (NASDAQ:SRRK) This Quarter
americanbankingnews.com - January 20 at 10:25 AM
MarketBeat logoScholar Rock (NASDAQ:SRRK) Reaches New 1-Year Low at $18.60
americanbankingnews.com - January 19 at 2:12 PM
MarketBeat logoScholar Rock (NASDAQ:SRRK) Reaches New 52-Week Low at $19.96
americanbankingnews.com - January 13 at 5:08 PM
finance.yahoo.com logoScholar Rock Provides Corporate Update and Highlights Priorities for 2022
finance.yahoo.com - January 10 at 8:59 AM
nasdaq.com logoScholar Rock Holding Corp Shares Approach 52-Week Low - Market Mover
nasdaq.com - January 8 at 2:16 PM
MarketBeat logoScholar Rock (NASDAQ:SRRK) Hits New 1-Year Low at $21.51
americanbankingnews.com - January 7 at 4:20 PM
finance.yahoo.com logoScholar Rock to Present at the 40th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 4 at 7:09 PM
markets.businessinsider.com logoScholar Rock Outlines Pivotal Apitegromab Trial Design In Spinal Muscular Atrophy Patients
markets.businessinsider.com - December 1 at 12:31 PM
finance.yahoo.com logoScholar Rock Announces Design of Phase 3 SAPPHIRE Clinical Trial Evaluating Apitegromab in Non-Ambulatory Patients with Type 2 and Type 3 Spinal Muscular Atrophy (SMA)
finance.yahoo.com - November 30 at 8:36 PM
benzinga.com logoNotable Scholar Rock Holding Insider Trades $2.8M In Company Stock
benzinga.com - November 16 at 12:38 PM
finance.yahoo.com logoScholar Rock Presents Data from Part A of the DRAGON Phase 1 Trial Evaluating SRK-181 as Monotherapy and in Combination with Anti-PD-(L)1 for the Treatment of Solid Tumors -- Announces Advancement into Part B
finance.yahoo.com - November 12 at 10:02 AM
finance.yahoo.com logoScholar Rock Holding Corporation (SRRK) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - November 9 at 2:10 PM
finance.yahoo.com logoScholar Rock Reports Third Quarter 2021 Financial Results and Highlights Business Progress
finance.yahoo.com - November 9 at 9:09 AM
finance.yahoo.com logoEarnings Preview: Scholar Rock Holding Corporation (SRRK) Q3 Earnings Expected to Decline
finance.yahoo.com - November 1 at 6:44 PM
finance.yahoo.com logoScholar Rock Holding Insider Sold $185K In Company Stock
finance.yahoo.com - October 6 at 12:41 PM
finance.yahoo.com logoScholar Rock to Present Apitegromab TOPAZ Phase 2 Pharmacologic Data at the 2021 World Congress of Neurology
finance.yahoo.com - October 3 at 8:16 AM
finance.yahoo.com logoScholar Rock Presents Exploratory Responder Analysis on Efficacy Data from the Apitegromab TOPAZ Phase 2 Trial at the Child Neurology Society Annual Meeting
finance.yahoo.com - September 30 at 2:03 PM
finance.yahoo.com logoScholar Rock Announces Issuance of U.S. Patent Protecting SRK-181, an Inhibitor of TGFβ1 Activation
finance.yahoo.com - September 28 at 7:48 PM
finance.yahoo.com logoScholar Rock Presents Additional Data Analyses from the Apitegromab TOPAZ Phase 2 Trial at the World Muscle Society 2021 Virtual Congress
finance.yahoo.com - September 23 at 1:45 PM
finance.yahoo.com logoScholar Rock to Present at the 2021 Cantor Virtual Global Healthcare Conference
finance.yahoo.com - September 22 at 5:15 PM
nasdaq.com logoShareholders have faith in loss-making Scholar Rock Holding (NASDAQ:SRRK) as stock climbs 9.0% in past week, taking one-year gain to 194%
nasdaq.com - August 16 at 5:47 PM
finance.yahoo.com logoScholar Rock Appoints Caryn Parlavecchio as Chief Human Resources Officer
finance.yahoo.com - August 16 at 5:47 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Scholar Rock Holding Corporation - SRRK
finance.yahoo.com - August 14 at 2:37 AM
finance.yahoo.com logoScholar Rock Reports Second Quarter 2021 Financial Results and Highlights Business Progress
finance.yahoo.com - August 10 at 8:37 PM
finance.yahoo.com logoScholar Rock Holding Corporation (SRRK) Reports Q2 Loss, Lags Revenue Estimates
finance.yahoo.com - August 10 at 8:37 PM
finance.yahoo.com logoScholar Rock Holding (NASDAQ:SRRK) shareholder returns have been solid, earning 173% in 3 years
finance.yahoo.com - August 10 at 3:36 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Scholar Rock Holding Corporation - SRRK
finance.yahoo.com - August 9 at 1:04 AM
finance.yahoo.com logoScholar Rock to Present at the 2021 Wedbush PacGrow Healthcare Conference
finance.yahoo.com - August 5 at 6:00 PM
marketwatch.com logoScholar Rock President, CEO Tony Kingsley Leaves >SRRK
marketwatch.com - August 3 at 1:32 PM
marketwatch.com logoScholar Rock Shares Fall After Departure of CEO Kingsley >SRRK
marketwatch.com - August 3 at 1:32 PM
finance.yahoo.com logoScholar Rock Announces Leadership Change
finance.yahoo.com - August 3 at 8:32 AM
finance.yahoo.com logoEarnings Preview: Scholar Rock Holding Corporation (SRRK) Q2 Earnings Expected to Decline
finance.yahoo.com - July 30 at 6:59 PM
finance.yahoo.com logoScholar Rock to Present Apitegromab TOPAZ Phase 2 Trial Results Highlighting Pharmacokinetic (PK) and Pharmacodynamic (PD) Data at the 2021 European Academy of Neurology Congress
finance.yahoo.com - June 18 at 8:21 AM
businesswire.com logoScholar Rock Presents TOPAZ Phase 2 Data Showing the Transformative Potential of Apitegromab in Patients with Type 2 and 3 Spinal Muscular Atrophy (SMA) at the 2021 Virtual SMA ...
businesswire.com - June 12 at 1:37 AM
marketwatch.com logoScholar Rock Up After Promising Data in Spinal Muscular Atrophy
marketwatch.com - June 11 at 8:33 PM
marketwatch.com logoScholar Rock: Data Shows Potential of Apitegromab in Spinal Muscular Atrophy
marketwatch.com - June 11 at 10:33 AM
finance.yahoo.com logoScholar Rock Presents TOPAZ Phase 2 Data Showing the Transformative Potential of Apitegromab in Patients with Type 2 and 3 Spinal Muscular Atrophy (SMA) at the 2021 Virtual SMA Research & Clinical Care Meeting
finance.yahoo.com - June 11 at 10:33 AM
businesswire.com logoScholar Rock to Present Apitegromab Clinical Data from the TOPAZ Phase 2 Trial in Patients with Type 2 and 3 Spinal Muscular Atrophy at the 2021 Virtual SMA Research & Clinical ...
businesswire.com - June 7 at 9:45 AM
finance.yahoo.com logoScholar Rock to Present Apitegromab Clinical Data from the TOPAZ Phase 2 Trial in Patients with Type 2 and 3 Spinal Muscular Atrophy at the 2021 Virtual SMA Research & Clinical Care Meeting
finance.yahoo.com - June 7 at 9:45 AM
finance.yahoo.com logoScholar Rock to Present at Upcoming Healthcare Conferences in June
finance.yahoo.com - May 27 at 9:32 AM
nasdaq.com logoScholar Rock Rings The Closing Bell
nasdaq.com - May 24 at 8:09 PM
finance.yahoo.com logoScholar Rock Receives Fast Track Designation from the U.S. FDA for Apitegromab for the Treatment of Patients with Spinal Muscular Atrophy
finance.yahoo.com - May 24 at 8:09 PM
benzinga.com logoScholar Rock to Present Trials in Progress Poster...
benzinga.com - May 19 at 10:47 PM
finance.yahoo.com logoScholar Rock to Present Trials in Progress Poster for SRK-181 DRAGON Phase 1 Clinical Trial at the American Society of Clinical Oncology Annual Meeting
finance.yahoo.com - May 19 at 5:46 PM
nasdaq.com logoAnalysts Have Been Trimming Their Scholar Rock Holding Corporation (NASDAQ:SRRK) Price Target After Its Latest Report
nasdaq.com - May 16 at 2:53 PM
finance.yahoo.com logoScholar Rock Reports First Quarter 2021 Financial Results and Highlights Business Progress
finance.yahoo.com - May 13 at 9:32 AM
finance.yahoo.com logoDoes Scholar Rock Holding (NASDAQ:SRRK) Have A Healthy Balance Sheet?
finance.yahoo.com - May 12 at 2:30 PM
finance.yahoo.com logoScholar Rock Announces Publication of Phase 1 Clinical Trial Data Evaluating Apitegromab in Healthy Volunteers in the Journal Advances in Therapy
finance.yahoo.com - May 11 at 5:25 PM
Get Scholar Rock News Delivered to You Automatically

Sign up to receive the latest news and ratings for SRRK and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/25/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.